Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-8775.8%
operating margin TTM
-9883.02%
revenue TTM
999.87 Million
revenue per share TTM
20.39$
valuation ratios | |
|---|---|
| pe ratio | -5.94 |
| peg ratio | 1.37 |
| price to book ratio | 1.50 |
| price to sales ratio | 521.01 |
| enterprise value multiple | -7.84 |
| price fair value | 1.50 |
profitability ratios | |
|---|---|
| gross profit margin | 2.02% |
| operating profit margin | -9883.02% |
| pretax profit margin | -8771.68% |
| net profit margin | -8775.8% |
| return on assets | -23.71% |
| return on equity | -23.12% |
| return on capital employed | -28.2% |
liquidity ratios | |
|---|---|
| current ratio | 13.26 |
| quick ratio | 13.26 |
| cash ratio | 12.94 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 365.00 |
| days of payables outstanding | 1,576.00 |
| cash conversion cycle | -1,211.00 |
| receivables turnover | 1.00 |
| payables turnover | 0.23 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.01 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -20,186.93 |
cash flow ratios | |
|---|---|
| free cash flow per share | -124.25 |
| cash per share | 0.70 |
| operating cash flow per share | -124.25 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -20,186.93 |
| short term coverage ratios | -32,968.86 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time MediciNova, Inc. (NASDAQ:MNOV) reported earnings?
MediciNova, Inc. (MNOV) published its most recent earnings results on 12-11-2025.
What is MediciNova, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. MediciNova, Inc. (NASDAQ:MNOV)'s trailing twelve months ROE is -23.12%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. MediciNova, Inc. (MNOV) currently has a ROA of -23.71%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MNOV's net profit margin stand at?
MNOV reported a profit margin of -8775.8% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MNOV's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 13.26 in the most recent quarter. The quick ratio stood at 13.26, with a Debt/Eq ratio of 0.01.